Keywords: merck, kgaa, erbitux, gets, broader, use, mcrc

Merck KGaA 's Erbitux gets broader use in mCRC

Article | 28 July 2008

Print This

Germany's Merck KGaA has been granted approval by the European Commission for Erbitux (cetuximab), to update its license for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in